SOURCE: BioMedReports


February 22, 2011 13:18 ET

Report: IPG Photonics Well Positioned in Growing Markets Like Healthcare

LOS ANGELES, CA--(Marketwire - February 22, 2011) - Investors are taking note of IPG Photonics Corporation in recent days. The firm, which was founded by a group of Russian scientists in the early 1990s develops and manufactures a broad line of high-performance fiber lasers for diverse applications in numerous markets. These are not the old, bulky, power hungry lasers that were unreliable and maintenance heavy. They are a new generation of lasers that are in high demand in several industries.

According to a recent report from Motley fool, none of the 11 analysts who were covering IPG, officially expected the company to earn more than $0.36 per share in the fourth quarter, but it appears that the company will not only beat those earnings estimates, they will do so convincingly. There has been an enthusiastic response to the pre-announcement by the company but official, audited earnings are set to be announced later this week.

The company's diverse lines of low, mid and high-power lasers and amplifiers are used in materials processing, advanced, communications and medical applications. Forecasts for the global market in these medical systems alone will compound annual growth rates (CAGRs) through 2014 according to industry reports.

This is one of the reasons why investors and Wall Street media outlets have become so bullish on the stock in recent weeks. Some analysts expect more positive developments from IPG's shares in 2011 given the company's dominant position in the various rapidly growing fiber laser markets and some overall steadily improving macroeconomic conditions.

A full special report about the market opportunity facing IPG Photonics is now available at:

Investors interested in accessing BioMedReports' complete database of clinical trials and upcoming FDA decisions can go to:

News developments and live healthcare sector updates are available constantly via twitter at:

About BioMedReports.Com

BioMedReports is a news portal covering the biomedical news and financial sector. BioMedReports is not paid or compensated to report the news and developments of publicly traded companies in the healthcare sector of the markets. Full disclosures and information is available at BioMedReports.Com

Contact Information

  • Media Contacts Only:

    Mary Davila
    Assistant Editor
    e-mail: Email Contact
    Tel: +1 323 472 4480
    Fax: +1 888 210 3556